Lim H, Park I, Kim M, Seo J, Ha G, Yang H
Foods. 2025; 14(4).
PMID: 40002076
PMC: 11854912.
DOI: 10.3390/foods14040632.
Chen Q, Shi J, Yu G, Xie H, Yu S, Xu J
Front Aging Neurosci. 2024; 16:1478557.
PMID: 39665039
PMC: 11632125.
DOI: 10.3389/fnagi.2024.1478557.
Bachelle S, Bah S, Addo R, Bediako-Bowan A, Egyir B, Tsatsu S
Sci Rep. 2024; 14(1):23195.
PMID: 39369124
PMC: 11455924.
DOI: 10.1038/s41598-024-74299-3.
Chen B, He J, Tian K, Qu J, Hong L, Lin Q
Molecules. 2024; 29(15).
PMID: 39124939
PMC: 11314202.
DOI: 10.3390/molecules29153534.
Oliero M, Alaoui A, McCartney C, Santos M
Gastroenterol Rep (Oxf). 2024; 12:goae058.
PMID: 38984069
PMC: 11231048.
DOI: 10.1093/gastro/goae058.
Antitumor Effect and Gut Microbiota Modulation by Quercetin, Luteolin, and Xanthohumol in a Rat Model for Colorectal Cancer Prevention.
Perez-Valero A, Magadan-Corpas P, Ye S, Serna-Diestro J, Sordon S, Huszcza E
Nutrients. 2024; 16(8).
PMID: 38674851
PMC: 11054239.
DOI: 10.3390/nu16081161.
Gut microbiota and their derivatives in the progression of colorectal cancer: Mechanisms of action, genome and epigenome contributions.
Ahmad A, Mahmood N, Raza M, Mushtaq Z, Saeed F, Afzaal M
Heliyon. 2024; 10(8):e29495.
PMID: 38655310
PMC: 11035079.
DOI: 10.1016/j.heliyon.2024.e29495.
A case-control study of the association between the gut microbiota and colorectal cancer: exploring the roles of diet, stress, and race.
Carson T, Byrd D, Smith K, Carter D, Gomez M, Abaskaron M
Gut Pathog. 2024; 16(1):13.
PMID: 38468325
PMC: 10929127.
DOI: 10.1186/s13099-024-00608-w.
Epigenetic effects of short-chain fatty acids from the large intestine on host cells.
Stein R, Riber L
Microlife. 2023; 4:uqad032.
PMID: 37441522
PMC: 10335734.
DOI: 10.1093/femsml/uqad032.
Berberine as a Potential Agent for the Treatment of Colorectal Cancer.
Jiang X, Jiang Z, Jiang M, Sun Y
Front Med (Lausanne). 2022; 9:886996.
PMID: 35572960
PMC: 9096113.
DOI: 10.3389/fmed.2022.886996.
Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?.
Lin Y, Kong D, Zhang Y
Front Oncol. 2022; 12:852194.
PMID: 35463305
PMC: 9023803.
DOI: 10.3389/fonc.2022.852194.
Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
Kim J, Lee H
Front Immunol. 2022; 12:807648.
PMID: 35069592
PMC: 8777015.
DOI: 10.3389/fimmu.2021.807648.
Colorectal Tumour Mucosa Microbiome Is Enriched in Oral Pathogens and Defines Three Subtypes That Correlate with Markers of Tumour Progression.
Zwinsova B, Petrov V, Hrivnakova M, Smatana S, Micenkova L, Kazdova N
Cancers (Basel). 2021; 13(19).
PMID: 34638284
PMC: 8507728.
DOI: 10.3390/cancers13194799.
Gut microbiota-derived metabolites in CRC progression and causation.
Dalal N, Jalandra R, Bayal N, Yadav A, Harshulika , Sharma M
J Cancer Res Clin Oncol. 2021; 147(11):3141-3155.
PMID: 34273006
DOI: 10.1007/s00432-021-03729-w.
The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response.
Sanchez-Alcoholado L, Ramos-Molina B, Otero A, Laborda-Illanes A, Ordonez R, Medina J
Cancers (Basel). 2020; 12(6).
PMID: 32486066
PMC: 7352899.
DOI: 10.3390/cancers12061406.
Association network analysis identifies enzymatic components of gut microbiota that significantly differ between colorectal cancer patients and healthy controls.
Ai D, Pan H, Li X, Wu M, Xia L
PeerJ. 2019; 7:e7315.
PMID: 31392094
PMC: 6673421.
DOI: 10.7717/peerj.7315.
Inferring Bacterial Infiltration in Primary Colorectal Tumors From Host Whole Genome Sequencing Data.
Guo M, Xu E, Ai D
Front Genet. 2019; 10:213.
PMID: 30930939
PMC: 6428740.
DOI: 10.3389/fgene.2019.00213.
Differential expression of tumor-associated genes and altered gut microbiome with decreased Akkermansia muciniphila confer a tumor-preventive microenvironment in intestinal epithelial Pten-deficient mice.
Howe C, Kim S, Mitchell J, Im E, Kim Y, Kim Y
Biochim Biophys Acta Mol Basis Dis. 2018; 1864(12):3746-3758.
PMID: 30292635
PMC: 6239937.
DOI: 10.1016/j.bbadis.2018.10.006.
The gut microbiome and colorectal cancer: a review of bacterial pathogenesis.
Dahmus J, Kotler D, Kastenberg D, Kistler C
J Gastrointest Oncol. 2018; 9(4):769-777.
PMID: 30151274
PMC: 6087872.
DOI: 10.21037/jgo.2018.04.07.
Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review.
Erben V, Bhardwaj M, Schrotz-King P, Brenner H
Cancers (Basel). 2018; 10(8).
PMID: 30060469
PMC: 6116151.
DOI: 10.3390/cancers10080246.